---
title: Simultaneous integrated boost to lateral pelvic lymph nodes during chemoradiotherapy
  in high-risk rectal cancer
date: '2025-01-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39808201/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250114170947&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: Preoperative chemoradiotherapy combined with total mesorectal
  excision (TME) is a standard treatment for locally advanced rectal cancer (LARC).
  However, lateral pelvic lymph nodes (LPLNs) are often inadequately treated with
  standard regimens. This study examines the treatment and postoperative outcomes
  in LARC patients receiving a simultaneous integrated boost (SIB) for LPLNs during
  long-course ...'
disable_comments: true
---
BACKGROUND: Preoperative chemoradiotherapy combined with total mesorectal excision (TME) is a standard treatment for locally advanced rectal cancer (LARC). However, lateral pelvic lymph nodes (LPLNs) are often inadequately treated with standard regimens. This study examines the treatment and postoperative outcomes in LARC patients receiving a simultaneous integrated boost (SIB) for LPLNs during long-course ...